Targeting BRD9 for Cancer Treatment: A New Strategy
Xiuzuo Zhu,1 Yi Liao,2 Liling Tang1 1Key Laboratory for Biorheological Science and Technology of Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, People’s Republic of China; 2Department of Thoracic Surgery, Southwest Hospital, Army Medical University (Thir...
Main Authors: | Zhu X, Liao Y, Tang L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/targeting-brd9-for-cancer-treatment-a-new-strategy-peer-reviewed-article-OTT |
Similar Items
-
BRD4: An emerging prospective therapeutic target in glioma
by: Hua Yang, et al.
Published: (2021-06-01) -
The Role of Bromodomain Containing Protein Nine (BRD9) in Melanogenesis and Melanoma
by: BASUROY, TUPA
Published: (2018) -
Targeting mechanotransduction at the transcriptional level: YAP and BRD4 are novel therapeutic targets for the reversal of liver fibrosis
by: Altynbek Zhubanchaliyev, et al.
Published: (2016-12-01) -
Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
by: Adam P. Cribbs, et al.
Published: (2021-02-01) -
A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
by: Zijun Zhou, et al.
Published: (2020-07-01)